Bacterial nanoplatform reprograms spleen immune cells to help prevent cancer recurrence

A research team led by Professor Yong Taik Lim at the SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, have developed an engineered nanoplatform named t-SMC (trained immunity-mediated splenic myelopoiesis converter), which precisely targets the spleen to reverse splenic myelopoiesis toward an antitumoral immune phenotype. The research is published in the journal Advanced Materials.

Read it at Phys.org ↗

← Front page